The bisphosphonate zoledronate prevents vertebral bone loss in mature estrogen-deficient rats as assessed by micro-computed tomography

The effect of long-term treatment with the bisphosphonate zoledronate on vertebral bone architecture was investigated in estrogen-deficient mature rats. 4-month-old rats were ovariectomized and development of cancellous osteopenia was assessed after 1 year. The change of bone architectural parameter...

Full description

Bibliographic Details
Main Author: Glatt M.
Format: Article
Language:English
Published: AO Research Institute Davos 2001-01-01
Series:European Cells & Materials
Online Access:http://www.ecmjournal.org/journal/papers/vol001/vol001a03.php